PUBLISHER: QYResearch | PRODUCT CODE: 1873661
PUBLISHER: QYResearch | PRODUCT CODE: 1873661
The global market for Knee Denervation was estimated to be worth US$ 354 million in 2024 and is forecast to a readjusted size of US$ 1253 million by 2031 with a CAGR of 20.3% during the forecast period 2025-2031.
This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Knee Denervation cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
Knee denervation is a minimally invasive medical procedure designed to reduce chronic knee pain, typically in patients with osteoarthritis or persistent pain following knee surgeries, such as knee replacements. The procedure involves selectively interrupting the sensory nerves that transmit pain signals from the knee to the brain. This is achieved without affecting motor function, thereby preserving joint movement.
Osteoarthritis (OA) is a degenerative disease common in synovial joints, which can cause degeneration of articular cartilage, bone hyperplasia at the joint margin and under the cartilage, etc. Knee osteoarthritis (KOA) is the most common knee disease in the limb joints. Domestic statistics show that more than 3% of people in my country suffer from OA, and KOA accounts for the majority. As my country gradually enters an aging society, the incidence of KOA is higher in the population. According to relevant data, the incidence rate in people over 60 years old is as high as 12%, and it is increasing with age.
KOA is essentially a degenerative disease and cannot be cured clinically. At present, KOA patients mostly use conservative treatments such as physical therapy, analgesics and intra-articular injections to control pain and improve their quality of life. Before drug intervention, there are auxiliary treatment measures such as physical therapy, exercise, and weight loss. It is generally believed that anti-inflammatory analgesics are the first choice for the treatment of KOA, but long-term use often produces adverse reactions. Intra-articular injection of glucocorticoids or sodium hyaluronate is believed to relieve inflammation in the joint and promote cartilage repair. Repeated injections can maintain the efficacy, but the effect will still decline after several years. Total knee arthroplasty (TKA) surgery is considered to be the only effective ultimate solution, but some patients still have poor postoperative effects or long-term postoperative pain. The urgent need for pain treatment in KOA patients has given rise to the application of Knee Denervation technology in this field.
Knee Denervation includes traditional radiofrequency ablation (RFA), pulsed radiofrequency (PRF), cooled RFA (CRF) and laser treatment. The principles, parameters and efficacy of Knee Denervation technology are still in the early stages, which leads to large differences in the technical methods used by different research teams. However, through a systematic evaluation of numerous clinical trials and case reports, it can still be concluded that Knee Denervation can relieve pain and improve quality of life for up to about 1 year in the treatment of postoperative pain after KOA or TKA, and has the advantages of less trauma and fewer complications.
According to our data, the global volume of Knee Denervation surgeries will be around 130,000 in 2024, and the volume is expected to reach 155,000 in 2025. The compound annual growth rate of Knee Denervation will reach more than 15% in the next five years, and the market size will exceed US$100 million by 2030. From a regional perspective, North America occupies a major position in the Knee Denervation industry with its complete medical facilities and advanced technology, with a market share of nearly 50% in 2024, followed by Europe and Asia Pacific. From a technical point of view, the main method of Knee Denervation is radiofrequency ablation, which will account for more than 90% in 2024, but laser therapy (invasive LA) and other methods are gradually showing their advantages and are developing rapidly.
With the extension of life expectancy, the health problems caused by degenerative diseases will inevitably become a major health threat. The knee joint is an important load-bearing joint in the human body. Chronic pain, especially KOA, will seriously reduce the quality of life of patients. Patients with moderate to severe or refractory KOA benefit less from traditional treatments and have to endure many adverse reactions. TKA surgery can only solve the problems of some patients. Some patients still have poor surgical results or do not have the conditions for surgical treatment. Knee Denervation for pain treatment has shown good therapeutic effects and high safety, and has huge market potential in the future.
This report aims to provide a comprehensive presentation of the global market for Knee Denervation, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Knee Denervation by region & country, by Type, and by Application.
The Knee Denervation market size, estimations, and forecasts are provided in terms of sales volume (Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Knee Denervation.
Market Segmentation
By Company
Segment by Type
Segment by Application
By Region
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Knee Denervation manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Knee Denervation in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Knee Denervation in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.